HIV plagues more than 25 million people in sub-Saharan Africa, according to the World Health Organization, and efforts to develop a vaccine against the virus have achieved limited success. But what if a vaccine against another sexually transmitted infection found widely in that region of Africa – chancroid – was relatively easy to develop and could reduce transmission of HIV as much as 10-fold?

